BlueRock Therapeutics company
BlueRock Therapeutics is a biotech company that plans to develop induced pluripotent stem cell (iPSC) therapies to cure a range of diseases using an industry-leading platform. One of the initial programs is to regenerate heart muscle in patients who have had a heart attack (myocard infarction, MI) or are suffering from chronic heart failure, leading causes of morbidity and mortality worldwid.
Technology:
Regenerative Medicine
Industry:
Biotechnology, Health Care, Science and Engineering
Headquarters:
Toronto, Ontario, Canada
Founded Date:
2016-01-01
Employees Number:
101-250
Funding Status:
M&A
Investors Number:
3
Total Funding:
$34.5M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series B
Register and Claim Ownership